EAACI High-Level EU Stakeholders Lunch: ‚ÄėWorking together to progress EU policies for the benefit of allergic patients in Europe‚Äô
The EAACI High-Level EU Stakeholders Lunch (June 13th 2016, Vienna) brought together representatives from the EU Institutions, patient advocates, allergy national societies, industry, and EAACI leadership to jointly reflect on collaborations to advance EU policies for the benefit of allergic patients.
Keynote addresses included:
- Professor Antonella Muraro (President of EAACI) who reiterated that success in tackling the allergy crisis in Europe requires partnerships between all interested stakeholders and continuous collaborations in EU actions at policy level;
- MEP Sirpa Pietika√Įnen (Chair of the European Parliament Interest Group on allergy and asthma) who highlighted the need for comprehensive EU-wide programmes on allergy and asthma building on existing national and regional best practices;
- Stefan Schreck (European Commission) who reminded that the Commission sees a clear added-value in having all Member States working together on chronic diseases at EU level, and hence will continue supporting such policy dialogue, where allergy and asthma should naturally be included;
- Professor Sergio Bonini (EMA) who stressed the importance of developing facilitated pathways for marketing authorisations of allergen product and to distinguish between allergen products used for in vivo diagnostics and products for allergen immunotherapy;
- Michele Antonelli (European Biopharmaceutical Entreprises & Stallergenes Greer) who confirmed the industry‚Äôs support to the development of precision medicine (PM) in allergy.
The moderated discussion was then the occasion for participants to hold fruitful discussions with the contribution of patient representatives from EAACI Patient Organisations Committee and EFA.
The 2016 high-level event was a successful step in the further engagement of the EAACI network in a dialogue to foster partnerships and collaboration between EU policy-making bodies and interested stakeholders to address allergy and asthma as part of the EU health and research policy actions.
You can read the full event report here, you can see the event agenda here and all pictures here.
Last updated: 24 August 2016
The Allergy Awareness Event ‚ÄúTest Your Allergies 2016‚ÄĚ in European Parliament ends with promising outcomes
From the 26th to the 28th of April, EAACI co-organised with the European Federation of Allergy and Airways Diseases Patients Associations (EFA) the Exhibition ‚ÄúTest Your Allergies 2016‚ÄĚ in the European Parliament in Brussels.
With nearly 400 people getting skin prick tested for allergies and visiting the exhibition site during the three days, the event successfully achieved its aim to raise awareness on the burden of allergies in Europe amongst EU policy-makers and the broader European civil society.
Initiated under the auspices of the European Parliament‚Äôs Interest Group on Allergy and Asthma and co-hosted by three of its members (Mrs Childers, Mrs Pietika√Įnen and Mr Borrelli), the event started with an opening cocktail conference on the 26th of April, during which fruitful discussions were conducted on how to better prevent and manage allergy in Europe.
Main highlights include:
‚ÄĘ Allergy and Asthma should be put at the forefront of EU Chronic Diseases policies given that they are the most common chronic diseases in Europe.
‚ÄĘ Building on the momentum generated at EU level on food improvement and the promotion of healthy food in light with the current EU policy priorities, advocacy actions may integrate food allergy issues as a core topic. Preventive measures should be promoted as regards food allergens, especially targeting children.
‚ÄĘ Enhancing collaboration with the patient community in advocacy should be considered an optimal means to achieve successful outcomes.
‚ÄĘ Addressing air quality issues and raising awareness on pollution levels in urban settings need to be amongst the focal points of further European policy actions
In conjunction to the event, EAACI Board of Officers had the opportunity to meet with key policy-makers in Brussels, including Health attach√©s from national governments and Members of the European Parliament. The meetings provided the occasion to inform on the organisation‚Äôs work and advocacy and discuss on improving the EU response to chronic diseases and allergy and foment research at European level in order to relieve the burden of patients affected by allergy and asthma across Europe.
As a result from this impactful advocacy actions, EAACI was delighted to welcome three new members in the European Parliament Interest Group on Allergy and Asthma: Mrs Renate Sommer (Germany, EPP Group), Mrs Dubravka Suica (Croatia, EPP Group) and MEP Christel Schaldemose (S&D, Denmark).Last updated: 19 May 2016
The European Parliament Interest Group on Allergy and Asthma presents ‚ÄúAllergy at the forefront of EU Chronic Diseases Policy: The road towards better prevention and management of Allergy in Europe‚ÄĚTuesday 26 April 2016 ‚Äď European Parliament, Brussels
Hosts: MEP Pietik√§inen, MEP Childers, MEP Borrelli
The European Parliament Interest Group on Allergy and Asthma invites you to the Allergy Exhibition - Test Your Allergies 2016 at the European Parliament in Brussels. To view the draft agenda of the opening meeting Click Here.
Last updated: 06 May 2016
On behalf of the European Academy of Allergy and Clinical, European Rhinologic Society and the European Medical Association, we cordially invite you to attend the European Symposium - European Need for Precision Medicine in Allergy and Airways Disease. This is the first visionary meeting on precision medicine in the field of the most prevalent non-communicable diseases in Europe, i.e. allergy and chronic airway diseases.
The symposium has the following aims:
1. Demonstrate the need for precision medicine in allergy and chronic airways disease in Europe
2. Define an action plan to deliver precision medicine in allergy and airways disease in Europe
When: Wednesday 14 October, 11:30 - 13:30
Where: European Parliament, Brussels
Last updated: 06 May 2016
From 7-9 January 2014, EAACI conducted three days of diagnostic tests for allergies in the European Parliament in Brussels. In total 350 people took the opportunity to be examined for sensitivity to the most common allergens and to be given an expert advice, and 47% of them tested positively.
The event was organised with the sponsorship of Claudiu Ciprian TńÉnńÉsescu MEP and the tests were conducted by a medical team led by Professor Peter Hellings, Professor at the Catholic University of Leuven and Clinic Head at the Department of Otorhinolaryngology of the University Hospitals Leuven.
‚ÄúMy team and I conducted diagnostic tests and provided advice non-stop on each of the three days. Some of the participants had quite severe symptoms. A first step towards helping patients with allergy should be to provide them with easier access to diagnosis‚ÄĚ, Professor Peter Hellings said.
"I am very happy that together with EAACI we have managed to facilitate an allergy test for a considerable number of people in the European Parliament. This common chronic disease has a serious impact on people‚Äôs lives, and I urge Member States to develop adequate national allergy programmes‚ÄĚ, Claudiu Ciprian TńÉnńÉsescu MEP said.Last updated: 06 May 2016
We need to secure real - time pollen monitoring in Europe!
Pollen emissions are not man-made and hence cannot be reduced by Member States action. That was the Commission‚Äôs reply to a question on facilitating real-time pollen monitoring in the EU, asked by the Italian MEP Andrea Zanoni earlier this year. While pollen might not be directly produced by humans, pollen emissions are very much affected by human activities. Therefore, EFA (the European Federation of Allergy and Airways Diseases Patients Associations), EAACI (the European Academy of Allergy and Clinical Immunology) and ERS (the European Respiratory Society) do not agree with this position.
Read more hereLast updated: 06 May 2016
Allergies are the most prevalent chronic diseases in Europe with a frequency > 20%. Allergic diseases to airborne allergens have been steadily increasing over the past few decades and an end to this increase is not in sight. Especially the younger generations show a higher incidence of allergic diseases. Thus, by the year 2040, 40% of the population will present an allergic predisposition in Europe.
The reasons for this steady increase are unclear. The Interest Group Aerobiology and Air Pollution of the EAACI (European Academy of Allergy and Clinical Immunology) organised a workshop on Wednesday, 21 March 2012, to inform stakeholders about the ongoing and future developments in allergy research in Europe to increase the public awareness for this ongoing epidemic.
This workshop gave up-to-date information about:
1. Current status of allergic diseases in Europe
2. Drivers of this allergic epidemic, including neophytes like Ambrosia artimisiifolia
3. Ongoing EU-funded projects on allergic diseases, like HIALINE
4. Highlight novel developments
5. Identify scientific areas that need additional EU-attention
6. Round table public discussion
Renowned speakers, researchers and opinion leaders in the investigation of allergic diseases took part in this meeting.
Participants: EU-Members of Parliament, EU-scientific officers, journalists, representatives of patient organisations and other interested stakeholders
On behalf of the Organising Committee,
Prof. Dr. J. Buters
Secretary of the Interest Group Aerobiology and Air PollutionLast updated: 06 May 2016
Report on the EFA ‚ÄúContains/May Contain ‚Äď Food Allergen Labelling‚ÄĚ Event
For food allergy patients, along with people who have hypersensitivities and intolerances, there are numerous issues of significance with the labelling of food items in Europe. Inaccurate, unavailable or misleading information, low readability, untrustworthy precautionary labelling for cross contamination, recipe changes or strange ingredients and language barriers are all equally concerning and can result in poor quality of life or nutrition, fear, restrictions, social isolation and even death. With this perspective, on the 19th of September 2012 at the European Parliament, the European Federation for Allergy and Airways Diseases Patients‚Äô Associations (EFA) organised an event specifically addressing ‚ÄúContains/May Contain ‚Äď Food Allergen Labelling.‚ÄĚ
Over the past year, the EFA Food Allergy Working Group has worked diligently to specify the topic as warranting a broader public dialogue in the context of the new EU Regulation on Food Information to Consumers. The event was coordinated by EFA‚Äôs EU Policy and Project Officer, Ms. Roberta Savli, in collaboration with our long standing partner the European Academy of Allergy and Clinical Immunology (EAACI) represented by Prof. Antonella Muraro Chair of the EAACI Food Allergy Guidelines project and EAACI Treasurer. It was hosted by Mrs. Renate Sommer, MEP, and Rapporteur of the Regulation. Please read more here.
‚ÄúEating safely: round table on European best practices on allergens labelling‚ÄĚ - 2014
In food allergy, the protection against symptoms is achieved by avoiding and abstaining consuming allergens. People with allergy or intolerance must therefore be able to identify the ingredients they are sensitive to. To improve safety and quality of life of people with allergy, the new European Union Regulation 1169/2011 ii on food information to consumers will enter into force on the 13 th of December 2014. Read more on the event organized by EFA in collaboration with EAACI here.Last updated: 06 May 2016
By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.